Results 61 to 70 of about 84,576 (334)

A computational model of contributors to pulmonary hypertensive disease: impacts of whole lung and focal disease distributions

Pulmonary Circulation, 2021
Pulmonary hypertension has multiple etiologies and so can be difficult to diagnose, prognose, and treat. Diagnosis is typically made via invasive hemodynamic measurements in the main pulmonary artery and is based on observed elevation of mean pulmonary ...
Behdad Shaarbaf Ebrahimi, Merryn H. Tawhai, Haribalan Kumar, Kelly S. Burrowes, Eric A. Hoffman, Margaret L. Wilsher, David Milne, Alys R. Clark   +7 more
doaj   +1 more source

Balloon Pulmonary Angioplasty: State of the Art

Interventional Cardiology: Reviews, Research, Resources, 2021
Balloon pulmonary angioplasty (BPA) is a novel technique for the treatment of chronic thromboembolic pulmonary hypertension. While cardiologists need no introduction to the concept of balloon angioplasty, BPA has its own particular challenges.
John G Coghlan, Alexander MK Rothman, Stephen P Hoole   +2 more
doaj   +1 more source

Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors. [PDF]

, 2014
The age at diagnosis of pulmonary arterial hypertension (PAH) and the prevalence of cardiovascular (CV) risk factors are increasing. We sought to determine whether the response to drug therapy was influenced by CV risk factors in PAH patients. We studied
Charalampopoulos, A, Connolly, SB, Davies, RJ, Gibbs, JS, Gin-Sing, W, Grapsa, J, Howard, LS, Nihoyannopoulos, P, Tzoulaki, I, Wilkins, MR   +9 more
core   +1 more source

Riociguat use in sickle cell related chronic thromboembolic pulmonary hypertension: A case series

Pulmonary Circulation, 2018
Adults with sickle cell disease can develop pulmonary hypertension from a multitude of etiologies. Classified as WHO Group 5, there are no therapies approved for the treatment of sickle cell disease-pulmonary hypertension.
Nargues A. Weir, Anna Conrey, Denise Lewis, Alem Mehari   +3 more
doaj   +1 more source

Chronic thromboembolic pulmonary hypertension: a review [PDF]

Singapore Medical Journal, 2021
Chronic thromboembolic pulmonary hypertension (CTEPH) is a unique form of pulmonary hypertension resulting from obstruction of the pulmonary artery by fibrotic thromboembolic material, usually initiated by recurrent or incomplete resolution of pulmonary embolism.
Cheryl Zhiya, Chong, Edgar Lik Wui, Tay, Ching Hui, Sia, Kian Keong, Poh   +3 more
openaire   +2 more sources

Chronic Thromboembolic Pulmonary Hypertension

JAMA
This JAMA Insights discusses the symptoms, diagnosis, and treatment of chronic thromboembolic pulmonary hypertension.
Rodolfo A, Estrada, William R, Auger, Sandeep, Sahay   +2 more
openaire   +4 more sources

MRI and clinical characteristics of suspected cerebrovascular accident in nine cats [PDF]

, 2017
Objectives Cerebrovascular accidents (CVAs) are infrequently reported in cats. To date, clinical characteristics, including lesion localisation and MRI findings, have only been reported in two cats.
Beltran, E, Drees, R, Wittaker, D E
core   +2 more sources

Time trends of pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension

Pulmonary Circulation, 2021
Chronic thromboembolic pulmonary hypertension is considered as a rare but severe complication after acute pulmonary embolism and is potentially curable by pulmonary endarterectomy.
Lukas Hobohm, Karsten Keller, Thomas Münzel, Stavros V. Konstantinides, Mareike Lankeit   +4 more
doaj   +1 more source

How should novelty be valued in science? [PDF]

, 2014
Box plot analysis of serum concentrations of sRAGE (A), esRAGE (B), S100A9 (C) and HMGB1 (D) in patients with CTEPH (n = 26) and controls (n = 33). Independent Student’s t-test was used to compare groups. RAGE receptor for advanced glycation endproducts,
Ana-Iris Schiefer (547363), Anna Megerle (625942), Bernhard Moser (221356), Christine Bekos (547365), Hendrik Jan Ankersmit (110152), Irene Lang (625943), Michael Mildner (110113), Nika Skoro-Sajer (625944), Peter Birner (285123), Roela Sadushi-Kolici (625945), Shahrokh Taghavi (625946), Stefan Janik (547362), Tamás Szerafin (545744), Walter Klepetko (110147)   +13 more
core   +4 more sources

Systematic pulmonary embolism follow-up increases diagnostic rates of chronic thromboembolic pulmonary hypertension and identifies less severe disease: results from the ASPIRE Registry

European Respiratory Journal
Extract Pulmonary embolism (PE) is a condition in which thrombus, usually embolised from the veins of the pelvis or lower limbs, obstructs the pulmonary arterial vascular bed.
C. Durrington, J. Hurdman, C. Elliot, Rhona Maclean, Joost Van Veen, Giorgia Sacccullo, Duneesha De-Foneska, Andrew J. Swift, S. Rajaram, C. Hill, S. Thomas, K. Dwivedi, S. Alabed, James M Wild, A. Charalampopoulos, A. Hameed, A. Rothman, L. Watson, N. Hamilton, A. Thompson, R. Condliffe, D. Kiely   +21 more
semanticscholar   +1 more source